Legis Daily

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

USA119th CongressHR-4392| House 
| Updated: 7/15/2025
Shontel M. Brown

Shontel M. Brown

Democratic Representative

Ohio

Cosponsors (43)
John W. Mannion (Democratic)Yassamin Ansari (Democratic)Robin L. Kelly (Democratic)Shomari Figures (Democratic)Robert Menendez (Democratic)Jennifer L. McClellan (Democratic)David Scott (Democratic)Frederica S. Wilson (Democratic)Terri A. Sewell (Democratic)Troy A. Carter (Democratic)Dina Titus (Democratic)Debbie Dingell (Democratic)Andrea Salinas (Democratic)Shri Thanedar (Democratic)Ro Khanna (Democratic)George Latimer (Democratic)Henry C. "Hank" Johnson (Democratic)Al Green (Democratic)Jill N. Tokuda (Democratic)Jahana Hayes (Democratic)Raja Krishnamoorthi (Democratic)LaMonica McIver (Democratic)Alma S. Adams (Democratic)Sydney Kamlager-Dove (Democratic)Lucy McBath (Democratic)Pramila Jayapal (Democratic)Bonnie Watson Coleman (Democratic)Lateefah Simon (Democratic)Maxine Waters (Democratic)Summer L. Lee (Democratic)Nydia M. Velázquez (Democratic)Cleo Fields (Democratic)Yvette D. Clarke (Democratic)Bennie G. Thompson (Democratic)Lori Trahan (Democratic)Lizzie Fletcher (Democratic)Luz M. Rivas (Democratic)Grace Meng (Democratic)Valerie P. Foushee (Democratic)Rashida Tlaib (Democratic)Ayanna Pressley (Democratic)Debbie Wasserman Schultz (Democratic)Lauren Underwood (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill authorizes the Secretary of Health and Human Services (HHS) to establish programs aimed at improving the early detection and intervention of uterine fibroids. A key component involves HHS conducting or supporting research to identify and formulate evidence-based strategies for increasing early detection in healthcare settings, which will then be made available for implementation by grantees. The legislation empowers the Secretary to award grants to States to carry out programs focused on increasing early detection and intervention for uterine fibroids, alongside developing public awareness and education campaigns. Grant funds can support activities like advanced gynecological imaging, patient navigation, implementing proven early detection strategies, and facilitating healthcare access, with priority given to States serving socially vulnerable populations at elevated risk. Additionally, the bill authorizes grants for further research, including clinical trials, into specific areas such as disparities in pain control and management for uterine fibroid surgical treatment, and other intrauterine conditions. The Act mandates regular reports to Congress every two years, summarizing grant program outcomes and outlining research developments.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-8247
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024
Jul 15, 2025
Introduced in House
Jul 15, 2025
Referred to the House Committee on Energy and Commerce.
Mar 19, 2026

Latest Companion Bill Action

S 119-2531
Committee on Health, Education, Labor, and Pensions. Hearings held.
  • Bill from Previous Congress

    HR 118-8247
    Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024


  • July 15, 2025
    Introduced in House


  • July 15, 2025
    Referred to the House Committee on Energy and Commerce.


  • March 19, 2026

    Latest Companion Bill Action

    S 119-2531
    Committee on Health, Education, Labor, and Pensions. Hearings held.

Health

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

USA119th CongressHR-4392| House 
| Updated: 7/15/2025
This bill authorizes the Secretary of Health and Human Services (HHS) to establish programs aimed at improving the early detection and intervention of uterine fibroids. A key component involves HHS conducting or supporting research to identify and formulate evidence-based strategies for increasing early detection in healthcare settings, which will then be made available for implementation by grantees. The legislation empowers the Secretary to award grants to States to carry out programs focused on increasing early detection and intervention for uterine fibroids, alongside developing public awareness and education campaigns. Grant funds can support activities like advanced gynecological imaging, patient navigation, implementing proven early detection strategies, and facilitating healthcare access, with priority given to States serving socially vulnerable populations at elevated risk. Additionally, the bill authorizes grants for further research, including clinical trials, into specific areas such as disparities in pain control and management for uterine fibroid surgical treatment, and other intrauterine conditions. The Act mandates regular reports to Congress every two years, summarizing grant program outcomes and outlining research developments.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-8247
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024
Jul 15, 2025
Introduced in House
Jul 15, 2025
Referred to the House Committee on Energy and Commerce.
Mar 19, 2026

Latest Companion Bill Action

S 119-2531
Committee on Health, Education, Labor, and Pensions. Hearings held.
  • Bill from Previous Congress

    HR 118-8247
    Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024


  • July 15, 2025
    Introduced in House


  • July 15, 2025
    Referred to the House Committee on Energy and Commerce.


  • March 19, 2026

    Latest Companion Bill Action

    S 119-2531
    Committee on Health, Education, Labor, and Pensions. Hearings held.
Shontel M. Brown

Shontel M. Brown

Democratic Representative

Ohio

Cosponsors (43)
John W. Mannion (Democratic)Yassamin Ansari (Democratic)Robin L. Kelly (Democratic)Shomari Figures (Democratic)Robert Menendez (Democratic)Jennifer L. McClellan (Democratic)David Scott (Democratic)Frederica S. Wilson (Democratic)Terri A. Sewell (Democratic)Troy A. Carter (Democratic)Dina Titus (Democratic)Debbie Dingell (Democratic)Andrea Salinas (Democratic)Shri Thanedar (Democratic)Ro Khanna (Democratic)George Latimer (Democratic)Henry C. "Hank" Johnson (Democratic)Al Green (Democratic)Jill N. Tokuda (Democratic)Jahana Hayes (Democratic)Raja Krishnamoorthi (Democratic)LaMonica McIver (Democratic)Alma S. Adams (Democratic)Sydney Kamlager-Dove (Democratic)Lucy McBath (Democratic)Pramila Jayapal (Democratic)Bonnie Watson Coleman (Democratic)Lateefah Simon (Democratic)Maxine Waters (Democratic)Summer L. Lee (Democratic)Nydia M. Velázquez (Democratic)Cleo Fields (Democratic)Yvette D. Clarke (Democratic)Bennie G. Thompson (Democratic)Lori Trahan (Democratic)Lizzie Fletcher (Democratic)Luz M. Rivas (Democratic)Grace Meng (Democratic)Valerie P. Foushee (Democratic)Rashida Tlaib (Democratic)Ayanna Pressley (Democratic)Debbie Wasserman Schultz (Democratic)Lauren Underwood (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted